trial · primary record
MK-1045
Follicular Lymphoma
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 960 |
| Primary completion | 2035-07-23 |
| Primary endpoint | Part 1: Number of Participants Who Experience an Adverse Event (AE) |
| Registry ID | NCT07634471 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:45.228Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07634471
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.